1,828
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Validation of a digit symbol substitution test for use in supervised and unsupervised assessment in mild Alzheimer’s disease

, , , , , & show all
Pages 768-779 | Received 19 Jul 2022, Accepted 07 Feb 2023, Published online: 22 Feb 2023

References

  • Akbar, N., Honarmand, K., Kou, N., & Feinstein, A. (2011). Validity of a computerized version of the symbol digit modalities test in multiple sclerosis. Journal of Neurology, 258(3), 373–379. https://doi.org/10.1007/s00415-010-5760-8
  • Amieva, H., Meillon, C., Proust-Lima, C., & Dartigues, J. F. (2019). Is low psychomotor speed a marker of brain vulnerability in late life? Digit symbol substitution test in the prediction of Alzheimer, Parkinson, stroke, disability, and depression. Dementia and Geriatric Cognitive Disorders, 47(4–6), 297–305. https://doi.org/10.1159/000500597
  • Ardila, A. (2005). Cultural values underlying psychometric cognitive testing. Neuropsychology Review, 15(4), 185–195. https://doi.org/10.1007/s11065-005-9180-y
  • Boeni, F., Spinatsch, E., Suter, K., Hersberger, K. E., & Arnet, I. (2014). Effect of drug reminder packaging on medication adherence: A systematic review revealing research gaps. Systematic Reviews, 3(1), 1. https://doi.org/10.1186/2046-4053-3-29
  • Centre for Drug Evaluation and Research. (2015). Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules: Guidance for Industry. https://www.fda.gov/files/drugs/published/Size–Shape–and-Other-Physical-Attributes-of-Generic-Tablets-and-Capsules.pdf
  • Centre for Drug Evaluation and Research. (2016). Safety considerations for product design to minimize medication errors: Guidance for industry. https://www.fda.gov/media/84903/download
  • Chaytor, N. S., Barbosa-Leiker, C., Germine, L. T., Fonseca, L. M., McPherson, S. M., & Tuttle, K. R. (2021). Construct validity, ecological validity and acceptance of self-administered online neuropsychological assessment in adults. Clinical Neuropsychologist, 35(1), 148–164. https://doi.org/10.1080/13854046.2020.1811893
  • Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Routledge Academic.
  • Conn, V. S., Ruppar, T. M., Chan, K. C., Dunbar-Jacob, J., Pepper, G. A., & de Geest, S. (2015). Packaging interventions to increase medication adherence: Systematic review and meta-analysis. Current Medical Research and Opinion, 31(1), 145–160. https://doi.org/10.1185/03007995.2014.978939
  • Colblindor. Coblis — Color Blindness Simulator. 2006-2021. https://www.color-blindness.com/coblis-color-blindness-simulator/
  • de La Plata, C. M., Vicioso, B., Hynan, L., Evans, H. M., Diaz-Arrastia, R., Lacritz, L., & Cullum, C. M. (2008). Development of the Texas Spanish naming test: A test for Spanish speakers. Clinical Neuropsychologist, 22(2), 288–304. https://doi.org/10.1080/13854040701250470
  • Donohue, M. C., Sperling, R. A., Salmon, D. P., Rentz, D. M., Raman, R., Thomas, R. G., Weiner, M., & Aisen, P. S. (2014). The preclinical Alzheimer cognitive composite: Measuring amyloid-related decline. JAMA Neurology, 71(8), 961–970. https://doi.org/10.1001/jamaneurol.2014.803
  • Dorman Marek, K., & Antle, L. (2008). Medication Management of the Community-Dwelling Older Adult. In R. G. Hughes (Ed.), Patient safety and quality. An Evidence-Based Handbook for Nurses: Vol. 1. Agency for Healthcare Research and Quality. 499–536.
  • Elliott, R. A., Goeman, D., Beanland, C., & Koch, S. (2015). Ability of older people with Dementia or cognitive impairment to manage medicine regimens: A narrative review. Current Clinical Pharmacology, 10(3), 213–221. https://doi.org/10.2174/1574884710666150812141525
  • Elliott, R. A., & Marriott, J. L. (2009). Standardised assessment of patients’ capacity to manage medications: A systematic review of published instruments. BMC Geriatrics, 9(1). https://doi.org/10.1186/1471-2318-9-27
  • European Medicines Agency. (2015). Good practice guide medication error risk minimisation and prevention. https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/good-practice-guide-risk-minimisation-prevention-medication-errors_en.pdf
  • Folstein, M. F., Folstein, S. E., & Mchugh, P. R. (1975). “Mini-Mental State”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)
  • Fowler, C., Rainey-Smith, S. R., Bird, S., Bomke, J., Bourgeat, P., Brown, B. M., Burnham, S. C., Bush, A. I., Chadunow, C., Collins, S., Doecke, J., Doré, V., Ellis, K. A., Evered, L., Fazlollahi, A., Fripp, J., Gardener, S. L., Gibson, S., Grenfell, R., & Ames, D. (2021). Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) study: Progress and observations from 2,359 older adults spanning the spectrum from cognitive normality to Alzheimer’s Disease. Journal of Alzheimer’s Disease Reports, 5(1), 443–468. https://doi.org/10.3233/ADR-210005
  • Germine, L., Nakayama, K., Duchaine, B. C., Chabris, C. F., Chatterjee, G., & Wilmer, J. B. (2012). Is the Web as good as the lab? Comparable performance from web and lab in cognitive/perceptual experiments. Psychonomic Bulletin & Review, 19(5), 847–857. https://doi.org/10.3758/s13423-012-0296-9
  • Harris, J. G., Wagner, B., & Cullum, C. M. (2007). Symbol vs. digit substitution task performance in diverse cultural and linguistic groups. Clinical Neuropsychologist, 21(5), 800–810. https://doi.org/10.1080/13854040600801019
  • Howieson, D. (2019). Current limitations of neuropsychological tests and assessment procedures. Clinical Neuropsychologist, 33(2), 200–208. https://doi.org/10.1080/13854046.2018.1552762
  • Insel, K., Morrow, D., Brewer, B., & Figueredo, A. (2006). Executive function, working memory, and medication adherence among older adults. Journal of Gerontology: Psychological Sciences, 61B(2), 102–107. https://doi.org/10.1093/geronb/61.2.P102
  • Jaeger, J. (2018). Digit symbol substitution test. Journal of Clinical Psychopharmacology, 38(5), 513–519. https://doi.org/10.1097/JCP.0000000000000941
  • Krueger, K. A., & Dayan, P. (2009). Flexible shaping: How learning in small steps helps. Cognition, 110(3), 380–394. https://doi.org/10.1016/j.cognition.2008.11.014
  • Lezak, M. D., Howieson, D. B., Bigler, E. D., & Tranel, D. (2012). Neuropsychological assessment (5th) ed.). Oxford University Press.
  • Lim, Y. Y., Ayton, D., Perin, S., Lavale, A., Yassi, N., Buckley, R., Barton, C., Bruns, L., Morello, R., Pirotta, S., Rosenich, E., Rajaratnam, S. M. W., Sinnott, R., Brodtmann, A., Bush, A. I., Maruff, P., Churilov, L., Barker, A., & Pase, M. P. (2021). An online, person-centered, risk factor management program to prevent cognitive decline: Protocol for a prospective behavior-modification blinded endpoint randomized controlled trial. Journal of Alzheimer’s Disease, 83(4), 1603–1622. https://doi.org/10.3233/JAD-210589
  • Lim, Y. Y., Ellis, K. A., Harrington, K., Kamer, A., Pietrzak, R. H., Bush, A. I., Darby, D., Martins, R. N., Masters, C. L., Rowe, C. C., Savage, G., Szoeke, C., Villemagne, V. L., Ames, D., & Maruff, P. (2013). Cognitive consequences of high aβ amyloid in mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer’s disease. Neuropsychology, 27(3), 322–332. https://doi.org/10.1037/a0032321
  • Lim, Y. Y., Harrington, K., Ames, D., Ellis, K. A., Lachovitzki, R., Snyder, P. J., & Maruff, P. (2012). Short term stability of verbal memory impairment in mild cognitive impairment and Alzheimer’s disease measured using the International shopping list test. Journal of Clinical and Experimental Neuropsychology, 34(8), 853–863. https://doi.org/10.1080/13803395.2012.689815
  • Morgan, T. K., Williamson, M., Pirotta, M., Stewart, K., Myers, S. P., & Barnes, J. (2012). A national census of medicines use: A 24-hour snapshot of Australians aged 50 years and older. Medical Journal of Australia, 196(1), 50–53. https://doi.org/10.5694/mja11.10698
  • Ng, K. P., Chiew, H. J., Lim, L., Rosa-Neto, P., Kandiah, N., & Gauthier, S. (2018). The influence of language and culture on cognitive assessment tools in the diagnosis of early cognitive impairment and dementia. Expert Review of Neurotherapeutics, 18(11), 859–869. https://doi.org/10.1080/14737175.2018.1532792
  • Perin, S., Buckley, R. F., Pase, M. P., Yassi, N., Lavale, A., Wilson, P. H., Schembri, A., Maruff, P., & Lim, Y. Y. (2020). Unsupervised assessment of cognition in the healthy brain project: Implications for web-based registries of individuals at risk for Alzheimer’s disease. Alzheimer’s and Dementia: Translational Research and Clinical Interventions, 6, 1. https://doi.org/10.1002/trc2.12043
  • Rapp, M. A., & Reischies, F. M. (2005). Attention and executive control predict Alzheimer Disease in late life: Results from the Berlin Aging Study (BASE). The American Journal of Geriatric Psychiatry, 13(2), 134–141. https://doi.org/10.1176/appi.ajgp.13.2.134
  • Rosselli, M., Uribe, I. V., Ahne, E., & Shihadeh, L. (2022). Culture, ethnicity, and level of education in Alzheimer’s Disease. Neurotherapeutics, 19(1), 26–54. https://doi.org/10.1007/s13311-022-01193-z
  • Sawilowsky, S. S. (2009). New effect size rules of thumb. Journal of Modern Applied Statistical Methods, 8(2), 597–599. https://doi.org/10.22237/jmasm/1257035100
  • Sayegh, P. (2015). Cross-Cultural issues in the neuropsycholgocail assessment of Dementia. In R. F. Ferraro (Ed.), Minority and cross-cultural aspects of neuropsychological assessment: Enduring and emerging trends (pp. 54–71). Taylor and Francis Group. http://ebookcentral.proquest.com/lib/monash/detail.action?docID=3569852
  • Skinner, B. F. (1938). The behavior of organisms: An experimental analysis. Appleton-Centyrt Crofts.
  • Spooner, D. M., & Pachana, N. A. (2006). Ecological validity in neuropsychological assessment: A case for greater consideration in research with neurologically intact populations. Archives of Clinical Neuropsychology, 21(4), 327–337. https://doi.org/10.1016/j.acn.2006.04.004
  • Spreen, O., & Strauss, E. (1998). A compendium of neuropsychological tests: Administration, norms and commentary (2nd) ed.). Oxford University Press.
  • Stilley, C. S., Bender, C. M., Dunbar-Jacob, J., Sereika, S., & Ryan, C. M. (2010). The impact of cognitive function on medication management: Three studies. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 29(1), 50–55. https://doi.org/10.1037/a0016940
  • Suchy, Y., Ziemnik, R. E., Niermeyer, M. A., & Brothers, S. L. (2020). Executive functioning interacts with complexity of daily life in predicting daily medication management among older adults. Clinical Neuropsychologist, 34(4), 797–825. https://doi.org/10.1080/13854046.2019.1694702
  • Teng, E. L., & Manly, J. J. (2005). Neuropsychological testing: Helpful or harmful? Alzheimer Disease and Associated Disorders, 19(4), 267–271. https://doi.org/10.1097/01.wad.0000190805.13126.8e
  • Thompson, F., Cysique, L. A., Harriss, L. R., Taylor, S., Savage, G., Maruff, P., & McDermott, R. (2020). Acceptability and usability of computerized cognitive assessment among Australian Indigenous residents of the Torres Strait Islands. Archives of Clinical Neuropsychology, 35(8), 1288–1302. https://doi.org/10.1093/arclin/acaa037
  • Thorndike, E. L. (1919). A standardized group examination of intelligence independent of language. Journal of Applied Psychology, 3(1), 13–32. https://doi.org/10.1037/h0070037
  • Tung, L. C., Yu, W. H., Lin, G. H., Yu, T. Y., Wu, C., Te, Tsai, C. Y., Chou, W., Chen, M. H., & Hsieh, C. L. (2016). Development of a tablet-based symbol digit modalities test for reliably assessing information processing speed in patients with stroke. Disability and Rehabilitation, 38(19), 1952–1960. https://doi.org/10.3109/09638288.2015.1111438
  • Weschler, D. (2008). Wechsler adult intelligence scale (4th) ed.). Pearson.
  • Wilson, B. A., Cockburn, J., & Baddeley, A. (1985). The Rivermead Behavioural Memory Test (RBMT). Thames Valley Test Company.
  • Zedler, B. K., Joyce, A., Murrelle, L., Kakad, P., & Harpe, S. E. (2011). A Pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use. Clinical Therapeutics, 33(5), 581–597. https://doi.org/10.1016/j.clinthera.2011.04.020